Skip to main content
Have a personal or library account? Click to login
Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections Cover

Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections

PRILOZI
Volume 36 (2015): Issue 2 (December 2015)
By: ,  ,   and    
Open Access
|Dec 2015
References

References

  1. Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powell D, et al. Double blind placebo-controlled trial of pleconaril in inmfants with enterovirus meningitis. Pediatr Infect Dis. 2003; 36: 1523-1532.
    Search in Google Scholar
  2. Aitken C, Jeffries DJ Nosocomial spread of viral disease. Clinical Microbiology Review. 2001; 14: 528-546.
    Open DOISearch in Google Scholar
  3. Archard LC, Richardson PJ, Olsen EG, Dubowitz V, Sewry C, Bowles NE. The role of coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp. 1987; 53: 51-62.
    Search in Google Scholar
  4. Aradottir E., Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with plrconaril. Pediatr Infect Dis. 2001; 20: 457-459.
    Open DOISearch in Google Scholar
  5. Chuang JH. (Enterovirus surveillance may be insufficient for estimating burden in Taiwan. Presented at: 14th International Congress on Infectious Diseases, March 9-12th, 2010; Miami, USA. Poster #40.005. 2010.
    Search in Google Scholar
  6. Diana GD, Rudewicz P., Pevear DC, Nitz TJ, Aldous SC, Robinson DT, et al. Picornavirus inhibitors: Trifluromethyl substitution provides a global protective effect against hepatic metabolism. J Med Chem. 1995; 38: 1355-1371.
    Open DOISearch in Google Scholar
  7. Galabov AS, Angelova A. Antiviral agents in the prevention and treatment of virus-induced diabetes. Anti-Infective Agents in Medicinal Chemistry. 2006; 5: 293-307.
    Open DOISearch in Google Scholar
  8. Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo- controlled trials. Clin Inf Dis. 2003; 36: 1523-1532.
    Open DOISearch in Google Scholar
  9. Herrmann EC Jr, Herrmann JA. A working hypothesis - virus resistance development as an indicator of specific antiviral activity. Ann NY Acad Sci. 1977; 284: 632-637.
    Open DOISearch in Google Scholar
  10. Herrmann EC Jr, Herrmann JA, DeLong DC. Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Res. 1982; 2: 339-346.
    Open DOISearch in Google Scholar
  11. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia. 2002; 45: 1353-1361
    Open DOISearch in Google Scholar
  12. Loddo B. Development of drug resistance and dependence in viruses. Pharm Ther. 1980; 10: 431-460
    Open DOISearch in Google Scholar
  13. Mallia P, Contoli M, Caramori G, Pandit A, Johnston SL, Papi A. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Current pahrmaceutical Design. 2007; 13: 73-97.
    Open DOISearch in Google Scholar
  14. Melnick JL, Crowther D, Barrera-Oro J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961; 134: 557-557.
    Open DOISearch in Google Scholar
  15. Morens DM, Pallansch MA. Epidemiology. In: Rotbart HA (ed) Human Enterovirus Infections. Washington DC ASM Press. 1995.
    Search in Google Scholar
  16. Nikolaeva L, Galabov AS. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta virol. 1995; 39: 235-241.
    Search in Google Scholar
  17. Nikolaeva L, Galabov AS. Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril. Acta virol. 1999a; 43: 263-265.
    Search in Google Scholar
  18. Nikolaeva L, Galabov AS. In vitro inhibitory effects of dual combinations of picornavirus replication inhibittors. Acta virol. 1999b; 43: 303-311.
    Search in Google Scholar
  19. Nikolaeva L, Galabov AS. Antiviral effect of the combination of enviroxim and disoxaril on Coxsackievirus B1 infection. Acta virol. 2000; 44: 73-78.
    Search in Google Scholar
  20. Nikolaeva-Glomb L, Galabov AS. Synergistic drug combinations against the in vitro replication of Coxackie B1 virus. Antiviral Res. 2004; 16: 41-46.
    Search in Google Scholar
  21. Nikolova I, Galabov AS. Development of resistance to disoxaril in coxsackie B1 virus infected newborn mice. Antivir Res. 2003; 60: 35-40.
    Open DOISearch in Google Scholar
  22. Pallansch M, Roos R. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, Howley PM (ed) Fields Virology, Fifth Edition, Philadelphia, Lippincott Williams & Wilkins. 2006; pp. 895-910.
    Search in Google Scholar
  23. Pallansch MA. Enterovirus infections, including poliomyelitis. In: Guerrant RL, Walker DH, Weller PF (ed) Tropical Infectious Diseases. Principles, Pathogens and Practice. 3rd edn. 2011.
    Open DOISearch in Google Scholar
  24. Prichard MN, Shipman CJr. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990; 14: 181-206.
    Open DOISearch in Google Scholar
  25. Rotbart HA, Webster AD. Treatment of potentially lifethreatening enterovirus infections with plrconaril. Clin Infect Dis. 2001; 32: 228-235.
    Open DOISearch in Google Scholar
  26. Schultheiss HP, Kuhl U. Overview on chronic viral cardiomyopathy/chronic myocarditis. Ernst Schering Res Found Workshop. 2006; 55: 3-18.
    Open DOISearch in Google Scholar
  27. Senior K. FDA panel rejects common cold treatment. Lancet Infect Dis. 2002; 2: 264.
    Open DOISearch in Google Scholar
  28. Strauss J, Strauss E. Plus-Strand RNA Viruses. In: Viruses and Human Disease. 2008; pp 63-136.
    Open DOISearch in Google Scholar
  29. Tan W C. Viruses in asthma exacerbations. Current Opinion in Pulmonary Medicine. 2005; 11: 21-26.
    Search in Google Scholar
  30. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol. 2011; 33: 45-55.
    Open DOISearch in Google Scholar
  31. Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob Agents Chemother. 1993; 33: 2069-2074.
    Open DOISearch in Google Scholar
  32. Turner RB, Hendley O. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother. 2005; 56: 805-807.
    Open DOISearch in Google Scholar
  33. Vassileva-Pencheva R, Galabov AS. Avoiding drug-resistance development by novel approach of combining enteroviral substances against coxsackievirus B1 infection in mice. Antiviral Res. 2010; 85: 366-372.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0057 | Journal eISSN: 1857-8985 (formerly 0350-1914) | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English, Russian
Page range: 91 - 99
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
enteroviruses,
antivirals,
drug-resistance,
combination effects
Related subjects:
Social sciences,
Education,
Education, other

© 2015 Angel S. Galabov, Ivanka Nikolova, Ralitsa Vassileva-Pencheva, Adelina Stoyanova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 36 (2015): Issue 2 (December 2015)
Previous article
Next article